Related Experiment Video
Updated: May 12, 2026

Evaluation of Coronary Flow Reserve After Myocardial Ischemia Reperfusion in Rats
Published on: June 28, 2019
Coronary microcirculation dysfunction causing ischemia with non-obstructive coronary arteries: a case report
Wei Qi1,2, Yazheng Zhang1,2, Le Wang1,2
1Department of Cardiology, Tianjin Chest Hospital, Tianjin, China.
Insights
This study details a case of Ischemia with No Obstructive Coronary Artery Disease (INOCA) caused by Coronary Microvascular Dysfunction (CMVD). A NOTCH1 gene variant was identified, potentially linking genetics to CMVD and INOCA.
Area of Science:
- Cardiology
- Genetics
- Vascular Biology
Background:
- Ischemia with No Obstructive Coronary Artery Disease (INOCA) affects patients with angina symptoms but without significant coronary artery blockages.
- Coronary Microvascular Dysfunction (CMVD) is an increasingly recognized cause of INOCA, involving impaired regulation of coronary blood flow.
- Understanding the underlying mechanisms of CMVD is crucial for accurate diagnosis and effective treatment of INOCA.
Observation:
- A 53-year-old male presented with exertional angina and myocardial ischemia (12% of left ventricle) despite normal coronary angiography.
- Diagnostic tests confirmed CMVD, showing an elevated Index of Microcirculatory Resistance (IMR) of 46.3 and a Quantitative Flow Ratio (QFR) of 0.94.
- Genetic analysis revealed a NOTCH1 gene variant (c.3862G>A) in the patient and family members, suggesting a potential genetic predisposition.
Findings:
- The identified NOTCH1 variant may contribute to CMVD by affecting vascular remodeling and microcirculatory control.
- Treatment with nicorandil, coenzyme Q10, trimetazidine, and rosuvastatin led to symptom resolution and reversal of myocardial ischemia.
- An MYH7 variant was detected but deemed clinically irrelevant due to the absence of cardiomyopathy in the family.
Implications:
- This case highlights a potential genetic link between NOTCH1 variants and INOCA secondary to CMVD.
- The findings support the need for further research into the role of NOTCH1 in vascular regulation and CMVD pathogenesis.
- This case provides a foundation for improved diagnosis and personalized management strategies for INOCA patients.
Abstract:
The study presents a case of INOCA attributed to CMVD in a 53-year-old male patient experiencing exertional angina, despite the absence of significant coronary artery stenosis on angiography. The patient presented with reversible myocardial ischemia detected by myocardial perfusion imaging, with an ischemic area accounting for 12% of the left ventricular wall. Diagnostic tests revealed an elevated index of microcirculatory resistance (IMR = 46.3) and a quantitative flow ratio (QFR = 0.94), confirming CMVD. Genetic testing identified a NOTCH1 c.3862G>A variant in the proband and some family members, suggesting a potential contribution to CMVD pathogenesis through impaired vascular remodeling and microcirculatory regulation. After six months of targeted treatment with nicorandil, coenzyme Q10, trimetazidine, and rosuvastatin, the patient's symptoms resolved, and myocardial ischemia reversed. While an MYH7 variant was also detected, its clinical relevance was ruled out due to the family's absence of associated cardiomyopathy phenotypes. The NOTCH1 gene may play a potential role in INOCA caused by CMVD, however, further research is needed to elucidate its underlying regulatory mechanisms. The findings provide a foundation for precise diagnosis and personalized management of INOCA.
More Related Videos
08:35Oxygenation-sensitive Cardiac MRI with Vasoactive Breathing Maneuvers for the Non-invasive Assessment of Coronary Microvascular Dysfunction
Published on: August 17, 2022
05:07Author Spotlight: Improved Localization and Monitoring of Coronary Flow Reserve Using Modified PLAX View in Mice
Published on: August 25, 2023
Related Concept Videos
Ischemic Heart Disease: Overview
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and narrowing...
Coronary Artery Disease I: Introduction
Coronary Artery Disease II: Pathophysiology
Coronary Artery Disease III: Clinical Manifestations
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations
Angina I: Introduction